Qt imaging granted renewal of nih sponsored study for early identification of response of breast cancer patients to neoadjuvant chemotherapy

Novato, calif.--(business wire)--qt imaging holdings, inc. (nasdaq:qti) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the third year renewal of its five-year research grant from the national institutes of health (nih)/national cancer institute (nci). the study is a collaboration with the department of radiation oncology, the radiation treatment program at the sunnybrook health sciences centre in toront.
QTI Ratings Summary
QTI Quant Ranking